Medical device stocks include companies manufacturing surgical instruments, diagnostic equipment, implants, and therapeutic devices. Our AI evaluates FDA approval pipelines, recurring revenue, and R&D efficiency from SEC filings.
Best Medical Devices Stocks to Buy in 2026
Top-rated medical devices stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: April 2026
MDXG
Confidence
92%
DXCM
Confidence
90%
ISRG
Confidence
90%
IDXX
Confidence
87%
SYK
Confidence
86%
INSP
Confidence
85%
EW
Confidence
85%
NBIX
Confidence
84%
IRMD
Confidence
83%
RSMDF
Confidence
82%
EXEL
Confidence
82%
LMAT
Confidence
80%
All Medical Devices Stocks (336)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| SIGY | Sigyn Therapeutics, Inc. | STRONG SELL | 98% | View Analysis → |
| QNCX | Quince Therapeutics, Inc. | STRONG SELL | 97% | View Analysis → |
| QCLS | Q/C TECHNOLOGIES, INC. | STRONG SELL | 97% | View Analysis → |
| RBOTW | Vicarious Surgical Inc. | STRONG SELL | 96% | View Analysis → |
| NIMU | NON INVASIVE MONITORING SYSTEMS INC /FL/ | STRONG SELL | 96% | View Analysis → |
| IRME | IR-Med, Inc. | STRONG SELL | 96% | View Analysis → |
| ENDV | ENDONOVO THERAPEUTICS, INC. | STRONG SELL | 96% | View Analysis → |
| COCHW | Envoy Medical, Inc. | STRONG SELL | 96% | View Analysis → |
| CDIOW | Cardio Diagnostics Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| BZYR | BURZYNSKI RESEARCH INSTITUTE INC | STRONG SELL | 96% | View Analysis → |
| BKHAR | Black Hawk Acquisition Corp | STRONG SELL | 96% | View Analysis → |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | STRONG SELL | 96% | View Analysis → |
| ARMP | Armata Pharmaceuticals, Inc. | STRONG SELL | 96% | View Analysis → |
| AIM | AIM ImmunoTech Inc. | STRONG SELL | 96% | View Analysis → |
| STME | Stimcell Energetics Inc. | STRONG SELL | 95% | View Analysis → |
| SNOA | Sonoma Pharmaceuticals, Inc. | STRONG SELL | 95% | View Analysis → |
| SGP | SpyGlass Pharma, Inc. | STRONG SELL | 95% | View Analysis → |
| SCLXW | Scilex Holding Co | STRONG SELL | 95% | View Analysis → |
| RVP | RETRACTABLE TECHNOLOGIES INC | STRONG SELL | 95% | View Analysis → |
| RTGN | RetinalGenix Technologies Inc. | STRONG SELL | 95% | View Analysis → |
| PSTV | PLUS THERAPEUTICS, INC. | STRONG SELL | 95% | View Analysis → |
| PREM | Premier Air Charter Holdings Inc. | STRONG SELL | 95% | View Analysis → |
| POSC | POSITRON CORP | STRONG SELL | 95% | View Analysis → |
| PMI | Picard Medical, Inc. | STRONG SELL | 95% | View Analysis → |
| PLUR | Pluri Inc. | STRONG SELL | 95% | View Analysis → |
| PAVM | PAVmed Inc. | STRONG SELL | 95% | View Analysis → |
| AVR | Anteris Technologies Global Corp. | STRONG SELL | 95% | View Analysis → |
| MCAGU | Mountain Crest Acquisition Corp. V | STRONG SELL | 94% | View Analysis → |
| LYRA | Lyra Therapeutics, Inc. | STRONG SELL | 94% | View Analysis → |
| IVF | INVO Fertility, Inc. | STRONG SELL | 94% | View Analysis → |
| EMED | Electromedical Technologies, Inc | STRONG SELL | 94% | View Analysis → |
| EBRCZ | EBR Systems, Inc. | STRONG SELL | 94% | View Analysis → |
| CRGT | Cortigent, Inc. | SELL | 94% | View Analysis → |
| CPMV | Mosaic ImmunoEngineering Inc. | STRONG SELL | 94% | View Analysis → |
| CODX | Co-Diagnostics, Inc. | STRONG SELL | 94% | View Analysis → |
| CEROW | CERO THERAPEUTICS HOLDINGS, INC. | STRONG SELL | 94% | View Analysis → |
| AWHL | Aspira Women's Health Inc. | STRONG SELL | 94% | View Analysis → |
| APTOF | Aptose Biosciences Inc. | STRONG SELL | 94% | View Analysis → |
| ALUR | ALLURION TECHNOLOGIES, INC. | STRONG SELL | 94% | View Analysis → |
| GCTK | Glucotrack, Inc. | STRONG SELL | 93% | View Analysis → |
| FTII | FutureTech II Acquisition Corp. | STRONG SELL | 93% | View Analysis → |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | STRONG SELL | 93% | View Analysis → |
| EXOZ | EXOZYMES INC. | STRONG SELL | 93% | View Analysis → |
| ESLAW | Estrella Immunopharma, Inc. | STRONG SELL | 93% | View Analysis → |
| ENZN | ENZON PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| BCAB | BioAtla, Inc. | STRONG SELL | 93% | View Analysis → |
| AVHHL | AVITA Medical, Inc. | STRONG SELL | 93% | View Analysis → |
| SLDB | Solid Biosciences Inc. | STRONG SELL | 92% | View Analysis → |
| SINT | Sintx Technologies, Inc. | STRONG SELL | 92% | View Analysis → |
| POCI | PRECISION OPTICS CORPORATION, INC. | STRONG SELL | 92% | View Analysis → |
| PHGE | BiomX Inc. | STRONG SELL | 92% | View Analysis → |
| ODYY | Odyssey Health, Inc. | STRONG SELL | 92% | View Analysis → |
| GTHP | GUIDED THERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| GPLB | Green Planet Bio Engineering Co. Ltd. | STRONG SELL | 92% | View Analysis → |
| NVACW | Profusa, Inc. | STRONG SELL | 92% | View Analysis → |
| NUMD | Nu-Med Plus, Inc. | STRONG SELL | 92% | View Analysis → |
| MDXG | MIMEDX GROUP, INC. | STRONG BUY | 92% | View Analysis → |
| MDAIW | Spectral AI, Inc. | STRONG SELL | 92% | View Analysis → |
| MBOT | Microbot Medical Inc. | STRONG SELL | 92% | View Analysis → |
| INKT | MiNK Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| FEMY | FEMASYS INC | STRONG SELL | 92% | View Analysis → |
| EDIT | Editas Medicine, Inc. | STRONG SELL | 92% | View Analysis → |
| DBVTF | DBV Technologies S.A. | STRONG SELL | 92% | View Analysis → |
| CUBT | Curative Biotechnology Inc | SELL | 92% | View Analysis → |
| CRIS | CURIS INC | STRONG SELL | 92% | View Analysis → |
| CLDX | Celldex Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CLDWW | Calidi Biotherapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| BTCY | BIOTRICITY INC. | STRONG SELL | 92% | View Analysis → |
| BJDX | Bluejay Diagnostics, Inc. | STRONG SELL | 92% | View Analysis → |
| BEATW | HeartBeam, Inc. | STRONG SELL | 92% | View Analysis → |
| BCDA | BioCardia, Inc. | STRONG SELL | 92% | View Analysis → |
| BBLGW | Bone Biologics Corp | STRONG SELL | 92% | View Analysis → |
| AMIX | Autonomix Medical, Inc. | STRONG SELL | 92% | View Analysis → |
| ALEC | Alector, Inc. | STRONG SELL | 92% | View Analysis → |
| MGTX | MeiraGTx Holdings plc | STRONG SELL | 91% | View Analysis → |
| DNABW | Ginkgo Bioworks Holdings, Inc. | STRONG SELL | 91% | View Analysis → |
| CVM | CEL SCI CORP | STRONG SELL | 91% | View Analysis → |
| CRDF | Cardiff Oncology, Inc. | STRONG SELL | 91% | View Analysis → |
| AURX | Nuo Therapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| ATRA | Atara Biotherapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| ALGS | Aligos Therapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| SSKN | STRATA Skin Sciences, Inc. | STRONG SELL | 90% | View Analysis → |
| OTLK | Outlook Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| NDRA | ENDRA Life Sciences Inc. | STRONG SELL | 90% | View Analysis → |
| LIMNW | Liminatus Pharma, Inc. | STRONG SELL | 90% | View Analysis → |
| NUWE | Nuwellis, Inc. | STRONG SELL | 90% | View Analysis → |
| MGX | Metagenomi Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| FNCH | Finch Therapeutics Group, Inc. | STRONG SELL | 90% | View Analysis → |
| FEED | ENvue Medical, Inc. | STRONG SELL | 90% | View Analysis → |
| DXCM | DEXCOM INC | STRONG BUY | 90% | View Analysis → |
| DRIO | DarioHealth Corp. | STRONG SELL | 90% | View Analysis → |
| CV | CapsoVision, Inc | STRONG SELL | 90% | View Analysis → |
| CUPR | Cuprina Holdings (Cayman) LTD | SELL | 90% | View Analysis → |
| CRBU | Caribou Biosciences, Inc. | SELL | 90% | View Analysis → |
| BMRA | BIOMERICA INC | STRONG SELL | 90% | View Analysis → |
| ATYR | aTYR PHARMA INC | STRONG SELL | 90% | View Analysis → |
| ISRG | INTUITIVE SURGICAL INC | BUY | 90% | View Analysis → |
| IBRX | ImmunityBio, Inc. | STRONG SELL | 89% | View Analysis → |
| ENTX | Entera Bio Ltd. | SELL | 89% | View Analysis → |
| APYX | Apyx Medical Corp | SELL | 89% | View Analysis → |
| SPAI | Safe Pro Group Inc. | STRONG SELL | 88% | View Analysis → |
| SNTI | Senti Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| SLXNW | Silexion Therapeutics Corp | STRONG SELL | 88% | View Analysis → |
| SGMO | SANGAMO THERAPEUTICS, INC | STRONG SELL | 88% | View Analysis → |
| RVMDW | Revolution Medicines, Inc. | STRONG SELL | 88% | View Analysis → |
| QTIWW | QT IMAGING HOLDINGS, INC. | STRONG SELL | 88% | View Analysis → |
| PETVW | PetVivo Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OSRHW | OSR Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OCGN | Ocugen, Inc. | STRONG SELL | 88% | View Analysis → |
| LUCD | Lucid Diagnostics Inc. | STRONG SELL | 88% | View Analysis → |
| LNSR | LENSAR, Inc. | STRONG SELL | 88% | View Analysis → |
| LFWD | Lifeward Ltd. | STRONG SELL | 88% | View Analysis → |
| INBX | Inhibrx Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | STRONG SELL | 88% | View Analysis → |
| HSCSW | HeartSciences Inc. | STRONG SELL | 88% | View Analysis → |
| RGNX | REGENXBIO Inc. | STRONG SELL | 88% | View Analysis → |
| RDGL | VIVOS INC | STRONG SELL | 88% | View Analysis → |
| MODD | Modular Medical, Inc. | STRONG SELL | 88% | View Analysis → |
| INMB | Inmune Bio, Inc. | SELL | 88% | View Analysis → |
| FATE | FATE THERAPEUTICS INC | SELL | 88% | View Analysis → |
| ELUT | ELUTIA INC. | SELL | 88% | View Analysis → |
| ECOR | electroCore, Inc. | SELL | 88% | View Analysis → |
| ARTV | Artiva Biotherapeutics, Inc. | SELL | 88% | View Analysis → |
| ARAY | ACCURAY INC | SELL | 88% | View Analysis → |
| TFX | TELEFLEX INC | SELL | 88% | View Analysis → |
| SRZNW | Surrozen, Inc./DE | STRONG SELL | 87% | View Analysis → |
| PLX | Protalix BioTherapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| IDXX | IDEXX LABORATORIES INC /DE | STRONG BUY | 87% | View Analysis → |
| GUTS | FRACTYL HEALTH, INC. | SELL | 87% | View Analysis → |
| MLSS | MILESTONE SCIENTIFIC INC. | STRONG SELL | 87% | View Analysis → |
| DYAI | DYADIC INTERNATIONAL INC | SELL | 87% | View Analysis → |
| DRTSW | Alpha Tau Medical Ltd. | SELL | 87% | View Analysis → |
| CLPT | ClearPoint Neuro, Inc. | SELL | 87% | View Analysis → |
| CADL | Candel Therapeutics, Inc. | SELL | 87% | View Analysis → |
| CABA | Cabaletta Bio, Inc. | SELL | 87% | View Analysis → |
| ATEC | Alphatec Holdings, Inc. | SELL | 87% | View Analysis → |
| GRST | ETHEMA HEALTH Corp | STRONG SELL | 86% | View Analysis → |
| NSPR | InspireMD, Inc. | STRONG SELL | 86% | View Analysis → |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | SELL | 86% | View Analysis → |
| LUNG | Pulmonx Corp | SELL | 86% | View Analysis → |
| LXEO | Lexeo Therapeutics, Inc. | SELL | 86% | View Analysis → |
| INTS | INTENSITY THERAPEUTICS, INC. | SELL | 86% | View Analysis → |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | SELL | 86% | View Analysis → |
| ESMC | ESCALON MEDICAL CORP | SELL | 86% | View Analysis → |
| DYNTQ | DYNATRONICS CORP | SELL | 86% | View Analysis → |
| DNLI | Denali Therapeutics Inc. | SELL | 86% | View Analysis → |
| SYK | STRYKER CORP | BUY | 86% | View Analysis → |
| ALLO | Allogene Therapeutics, Inc. | SELL | 86% | View Analysis → |
| STEX | Streamex Corp. | STRONG SELL | 85% | View Analysis → |
| SSII | SS Innovations International, Inc. | STRONG SELL | 85% | View Analysis → |
| SI | SHOULDER INNOVATIONS, INC. | STRONG SELL | 85% | View Analysis → |
| QDEL | QuidelOrtho Corp | STRONG SELL | 85% | View Analysis → |
| PTHS | Pelthos Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| PROK | PROKIDNEY CORP. | STRONG SELL | 85% | View Analysis → |
| PCVX | Vaxcyte, Inc. | STRONG SELL | 85% | View Analysis → |
| NXGLW | NEXGEL, INC. | SELL | 85% | View Analysis → |
| NRXS | Neuraxis, INC | STRONG SELL | 85% | View Analysis → |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | SELL | 85% | View Analysis → |
| INSP | Inspire Medical Systems, Inc. | BUY | 85% | View Analysis → |
| FDMT | 4D Molecular Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CVRX | CVRx, Inc. | SELL | 85% | View Analysis → |
| CMPX | Compass Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CHRS | Coherus Oncology, Inc. | SELL | 85% | View Analysis → |
| CGEM | Cullinan Therapeutics, Inc. | SELL | 85% | View Analysis → |
| EW | Edwards Lifesciences Corp | BUY | 85% | View Analysis → |
| NBIX | NEUROCRINE BIOSCIENCES INC | BUY | 84% | View Analysis → |
| IMDX | Insight Molecular Diagnostics Inc. | STRONG SELL | 84% | View Analysis → |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | STRONG SELL | 84% | View Analysis → |
| NTRBW | NutriBand Inc. | SELL | 84% | View Analysis → |
| MAZE | Maze Therapeutics, Inc. | SELL | 84% | View Analysis → |
| IRIX | IRIDEX CORP | SELL | 84% | View Analysis → |
| IPHYF | Innate Pharma SA | SELL | 84% | View Analysis → |
| ENOV | Enovis CORP | SELL | 84% | View Analysis → |
| ENGNW | enGene Holdings Inc. | SELL | 84% | View Analysis → |
| ECIA | ENCISION INC | SELL | 84% | View Analysis → |
| DTIL | PRECISION BIOSCIENCES INC | SELL | 84% | View Analysis → |
| CTSO | Cytosorbents Corp | SELL | 84% | View Analysis → |
| CGTX | COGNITION THERAPEUTICS INC | SELL | 84% | View Analysis → |
| CCCC | C4 Therapeutics, Inc. | SELL | 84% | View Analysis → |
| BDMDW | Baird Medical Investment Holdings Ltd | SELL | 84% | View Analysis → |
| AUTL | Autolus Therapeutics plc | SELL | 84% | View Analysis → |
| AURA | Aura Biosciences, Inc. | SELL | 84% | View Analysis → |
| HUMAW | Humacyte, Inc. | STRONG SELL | 83% | View Analysis → |
| IRMD | IRADIMED CORP | BUY | 83% | View Analysis → |
| EVAX | Evaxion A/S | SELL | 83% | View Analysis → |
| CGON | CG Oncology, Inc. | SELL | 83% | View Analysis → |
| RSMDF | RESMED INC | STRONG BUY | 82% | View Analysis → |
| PLSE | PULSE BIOSCIENCES, INC. | STRONG SELL | 82% | View Analysis → |
| OSUR | ORASURE TECHNOLOGIES INC | SELL | 82% | View Analysis → |
| NXL | Nexalin Technology, Inc. | STRONG SELL | 82% | View Analysis → |
| MYO | MYOMO, INC. | SELL | 82% | View Analysis → |
| LAKE | LAKELAND INDUSTRIES INC | SELL | 82% | View Analysis → |
| JSPRW | Jasper Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| NMRA | Neumora Therapeutics, Inc. | SELL | 82% | View Analysis → |
| INGN | Inogen Inc | SELL | 82% | View Analysis → |
| EXEL | EXELIXIS, INC. | BUY | 82% | View Analysis → |
| CRSP | CRISPR Therapeutics AG | SELL | 82% | View Analysis → |
| APGE | Apogee Therapeutics, Inc. | SELL | 82% | View Analysis → |
| BDX | BECTON DICKINSON & CO | SELL | 82% | View Analysis → |
| NTLA | Intellia Therapeutics, Inc. | SELL | 81% | View Analysis → |
| AVXL | ANAVEX LIFE SCIENCES CORP. | SELL | 81% | View Analysis → |
| PASG | Passage BIO, Inc. | STRONG SELL | 80% | View Analysis → |
| LMAT | LEMAITRE VASCULAR INC | BUY | 80% | View Analysis → |
| KRYS | Krystal Biotech, Inc. | BUY | 80% | View Analysis → |
| KOD | Kodiak Sciences Inc. | SELL | 80% | View Analysis → |
| MMSI | MERIT MEDICAL SYSTEMS INC | BUY | 80% | View Analysis → |
| ELMD | Electromed, Inc. | BUY | 80% | View Analysis → |
| CYH | COMMUNITY HEALTH SYSTEMS INC | SELL | 80% | View Analysis → |
| CBLL | Ceribell, Inc. | SELL | 80% | View Analysis → |
| CARL | CARLSMED, INC. | SELL | 80% | View Analysis → |
| BEAM | Beam Therapeutics Inc. | SELL | 80% | View Analysis → |
| BBNX | Beta Bionics, Inc. | SELL | 80% | View Analysis → |
| MDT | Medtronic plc | BUY | 80% | View Analysis → |
| BSX | BOSTON SCIENTIFIC CORP | BUY | 80% | View Analysis → |
| BAX | BAXTER INTERNATIONAL INC | SELL | 80% | View Analysis → |
| FENC | FENNEC PHARMACEUTICALS INC. | SELL | 79% | View Analysis → |
| STE | STERIS plc | BUY | 78% | View Analysis → |
| SRRK | Scholar Rock Holding Corp | SELL | 78% | View Analysis → |
| SMTI | Sanara MedTech Inc. | SELL | 78% | View Analysis → |
| SGHT | Sight Sciences, Inc. | SELL | 78% | View Analysis → |
| SABSW | SAB Biotherapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| PRME | Prime Medicine, Inc. | STRONG SELL | 78% | View Analysis → |
| PMCB | PharmaCyte Biotech, Inc. | SELL | 78% | View Analysis → |
| PEN | Penumbra Inc | BUY | 78% | View Analysis → |
| NEOG | NEOGEN CORP | SELL | 78% | View Analysis → |
| MYGN | MYRIAD GENETICS INC | SELL | 78% | View Analysis → |
| IMA | ImageneBio, Inc. | SELL | 78% | View Analysis → |
| GMED | GLOBUS MEDICAL INC | BUY | 78% | View Analysis → |
| GIPL | Global Innovative Platforms Inc. | SELL | 78% | View Analysis → |
| RLAY | Relay Therapeutics, Inc. | SELL | 78% | View Analysis → |
| MNESP | MSA Safety Inc | BUY | 78% | View Analysis → |
| IVVD | Invivyd, Inc. | SELL | 78% | View Analysis → |
| IPSC | Century Therapeutics, Inc. | SELL | 78% | View Analysis → |
| INFU | InfuSystem Holdings, Inc | BUY | 78% | View Analysis → |
| CERS | CERUS CORP | SELL | 78% | View Analysis → |
| CDRE | Cadre Holdings, Inc. | BUY | 78% | View Analysis → |
| AXGN | Axogen, Inc. | SELL | 78% | View Analysis → |
| WST | WEST PHARMACEUTICAL SERVICES INC | BUY | 78% | View Analysis → |
| UHS | UNIVERSAL HEALTH SERVICES INC | BUY | 78% | View Analysis → |
| LONA | LeonaBio, Inc. | SELL | 77% | View Analysis → |
| AVNS | AVANOS MEDICAL, INC. | SELL | 77% | View Analysis → |
| NVNO | enVVeno Medical Corp | STRONG SELL | 76% | View Analysis → |
| NEPH | NEPHROS INC | BUY | 76% | View Analysis → |
| LGMK | LogicMark, Inc. | SELL | 76% | View Analysis → |
| LCTX | Lineage Cell Therapeutics, Inc. | SELL | 76% | View Analysis → |
| KYMR | Kymera Therapeutics, Inc. | SELL | 76% | View Analysis → |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | SELL | 76% | View Analysis → |
| MRNA | Moderna, Inc. | SELL | 76% | View Analysis → |
| DCTH | DELCATH SYSTEMS, INC. | BUY | 76% | View Analysis → |
| CSBR | CHAMPIONS ONCOLOGY, INC. | SELL | 76% | View Analysis → |
| ANGO | ANGIODYNAMICS INC | SELL | 76% | View Analysis → |
| ALGN | ALIGN TECHNOLOGY INC | BUY | 76% | View Analysis → |
| SKIN | Beauty Health Co | SELL | 75% | View Analysis → |
| RXRX | RECURSION PHARMACEUTICALS, INC. | SELL | 75% | View Analysis → |
| PROF | Profound Medical Corp. | SELL | 75% | View Analysis → |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SELL | 75% | View Analysis → |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | BUY | 75% | View Analysis → |
| HCA | HCA Healthcare, Inc. | BUY | 75% | View Analysis → |
| OM | Outset Medical, Inc. | SELL | 74% | View Analysis → |
| OBIO | Orchestra BioMed Holdings, Inc. | SELL | 74% | View Analysis → |
| LENZ | LENZ Therapeutics, Inc. | SELL | 74% | View Analysis → |
| KYTX | Kyverna Therapeutics, Inc. | SELL | 74% | View Analysis → |
| REPL | Replimune Group, Inc. | STRONG SELL | 74% | View Analysis → |
| CNMD | CONMED Corp | SELL | 74% | View Analysis → |
| BDTX | Black Diamond Therapeutics, Inc. | BUY | 74% | View Analysis → |
| PDEX | PRO DEX INC | BUY | 73% | View Analysis → |
| STIM | Neuronetics, Inc. | SELL | 72% | View Analysis → |
| SRTS | Sensus Healthcare, Inc. | SELL | 72% | View Analysis → |
| SNWV | SANUWAVE Health, Inc. | SELL | 72% | View Analysis → |
| SGRY | Surgery Partners, Inc. | HOLD | 72% | View Analysis → |
| SANA | Sana Biotechnology, Inc. | SELL | 72% | View Analysis → |
| PRCT | PROCEPT BioRobotics Corp | SELL | 72% | View Analysis → |
| PODD | INSULET CORP | BUY | 72% | View Analysis → |
| LNTH | Lantheus Holdings, Inc. | BUY | 72% | View Analysis → |
| HYPR | Hyperfine, Inc. | SELL | 72% | View Analysis → |
| MDNC | Medinotec Inc. | BUY | 72% | View Analysis → |
| MDLN | Medline Inc. | BUY | 72% | View Analysis → |
| BCRX | BIOCRYST PHARMACEUTICALS INC | BUY | 72% | View Analysis → |
| APT | ALPHA PRO TECH LTD | HOLD | 72% | View Analysis → |
| NVCR | NovoCure Ltd | SELL | 71% | View Analysis → |
| HAE | HAEMONETICS CORP | BUY | 71% | View Analysis → |
| NPCE | NeuroPace Inc | SELL | 71% | View Analysis → |
| SOLV | Solventum Corp | HOLD | 70% | View Analysis → |
| KIDS | ORTHOPEDIATRICS CORP | SELL | 70% | View Analysis → |
| ICCC | IMMUCELL CORP /DE/ | BUY | 70% | View Analysis → |
| MASI | MASIMO CORP | HOLD | 70% | View Analysis → |
| ITGR | Integer Holdings Corp | HOLD | 70% | View Analysis → |
| IRTC | iRhythm Holdings, Inc. | HOLD | 70% | View Analysis → |
| FONR | FONAR CORP | HOLD | 70% | View Analysis → |
| EMBC | Embecta Corp. | HOLD | 70% | View Analysis → |
| MMM | 3M CO | HOLD | 70% | View Analysis → |
| IKT | Inhibikase Therapeutics, Inc. | SELL | 69% | View Analysis → |
| GLUE | Monte Rosa Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| ARDT | Ardent Health, Inc. | HOLD | 69% | View Analysis → |
| AORT | ARTIVION, INC. | HOLD | 69% | View Analysis → |
| PALI | PALISADE BIO, INC. | SELL | 68% | View Analysis → |
| OFIX | Orthofix Medical Inc. | SELL | 68% | View Analysis → |
| LIVN | LivaNova PLC | HOLD | 68% | View Analysis → |
| ICUI | ICU MEDICAL INC/DE | SELL | 68% | View Analysis → |
| GKOS | GLAUKOS Corp | SELL | 68% | View Analysis → |
| BVS | Bioventus Inc. | HOLD | 68% | View Analysis → |
| BIIB | BIOGEN INC. | HOLD | 68% | View Analysis → |
| ATRC | AtriCure, Inc. | BUY | 68% | View Analysis → |
| ANIK | Anika Therapeutics, Inc. | HOLD | 68% | View Analysis → |
| SIBN | SI-BONE, Inc. | BUY | 67% | View Analysis → |
| NVAX | NOVAVAX INC | SELL | 67% | View Analysis → |
| KRMD | KORU Medical Systems, Inc. | BUY | 67% | View Analysis → |
| BLFS | BIOLIFE SOLUTIONS INC | BUY | 67% | View Analysis → |
| IMVT | Immunovant, Inc. | SELL | 66% | View Analysis → |
| IMCR | Immunocore Holdings plc | BUY | 66% | View Analysis → |
| IDXG | INTERPACE BIOSCIENCES, INC. | HOLD | 65% | View Analysis → |
| ICUCW | SeaStar Medical Holding Corp | SELL | 65% | View Analysis → |
| RGEN | REPLIGEN CORP | HOLD | 65% | View Analysis → |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | HOLD | 64% | View Analysis → |
| HCIL | Hongchang International Co., Ltd | SELL | 64% | View Analysis → |
| HALO | HALOZYME THERAPEUTICS, INC. | BUY | 64% | View Analysis → |
| KLRS | Kalaris Therapeutics, Inc. | SELL | 60% | View Analysis → |
| HTFL | Heartflow, Inc. | HOLD | 60% | View Analysis → |
| NNNN | Anbio Biotechnology | SELL | 60% | View Analysis → |
| INAB | IN8BIO, INC. | SELL | 58% | View Analysis → |
| ARGX | ARGENX SE | BUY | 50% | View Analysis → |
| CLGN | CollPlant Biotechnologies Ltd | SELL | 48% | View Analysis → |
| CGEN | COMPUGEN LTD | HOLD | 47% | View Analysis → |
| CLLS | Cellectis S.A. | SELL | 44% | View Analysis → |
| BNTX | BioNTech SE | HOLD | 44% | View Analysis → |
| INMD | InMode Ltd. | HOLD | 42% | View Analysis → |
| EIKN | Eikon Therapeutics, Inc. | HOLD | 41% | View Analysis → |
| BRSYF | Brainsway Ltd. | BUY | 40% | View Analysis → |
| ALVOW | Alvotech | HOLD | 40% | View Analysis → |
| EDAP | EDAP TMS SA | HOLD | 39% | View Analysis → |
| CRDL | Cardiol Therapeutics Inc. | HOLD | 39% | View Analysis → |
| MOLN | MOLECULAR PARTNERS AG | HOLD | 18% | View Analysis → |
| MMED | MiniMed Group, Inc. | SELL | 18% | View Analysis → |
| RGNT | REGENTIS BIOMATERIALS LTD. | HOLD | 16% | View Analysis → |
| MEOBF | MESOBLAST LTD | HOLD | 5% | View Analysis → |
Frequently Asked Questions: Medical Devices Stocks
What are the best medical devices stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 47 medical devices stocks have Buy or Strong Buy ratings in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which medical devices stocks have Strong Buy ratings?
Currently, 4 medical devices stocks have a Strong Buy rating from our AI analysis. Strong Buy indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze medical devices stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Medical devices stocks with 80%+ confidence have the most reliable ratings.
Should I invest in medical devices stocks in 2026?
Our AI analysis shows 47 Buy ratings vs 259 Sell ratings in the medical devices sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are medical devices stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most medical devices stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for medical devices stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.
Compare Top Medical Devices Stocks
Part of: 💊 Healthcare Sector